United States - English - NLM (National Library of Medicine)

physicians total care, inc. - theophylline anhydrous (unii: 0i55128jyk) (theophylline anhydrous - unii:0i55128jyk) - theophylline anhydrous 100 mg - theophylline extended-release tablets are indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. theophylline extended-release tablets are contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product.

Ireland - English - HPRA (Health Products Regulatory Authority)

mundipharma pharmaceuticals limited - theophylline - prolonged-release tablet - 200 milligram(s) - xanthines; theophylline

Ireland - English - HPRA (Health Products Regulatory Authority)

mundipharma pharmaceuticals limited - theophylline - prolonged-release tablet - 300 milligram(s) - xanthines; theophylline

Ireland - English - HPRA (Health Products Regulatory Authority)

mundipharma pharmaceuticals limited - theophylline - prolonged-release tablet - 400 milligram(s) - xanthines; theophylline

Ireland - English - HPRA (Health Products Regulatory Authority)

ennogen healthcare (europe) limited - theophylline - prolonged-release tablet - xanthines; theophylline

Ireland - English - HPRA (Health Products Regulatory Authority)

ennogen healthcare (europe) limited - theophylline - prolonged-release tablet - xanthines; theophylline

Ireland - English - HPRA (Health Products Regulatory Authority)

ennogen healthcare (europe) limited - theophylline - prolonged-release tablet - xanthines; theophylline

United States - English - NLM (National Library of Medicine)

marlex pharmaceuticals inc - theophylline anhydrous (unii: 0i55128jyk) (theophylline anhydrous - unii:0i55128jyk) - theophylline anhydrous 80 mg in 15 ml - theophylline is indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. theophylline oral solution, usp is contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product.

United States - English - NLM (National Library of Medicine)

pack pharmaceuticals, llc - theophylline anhydrous (unii: 0i55128jyk) (theophylline anhydrous - unii:0i55128jyk) - theophylline anhydrous 400 mg - theophylline is indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. theophylline (anhydrous) extended-release tablets is contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product.

United States - English - NLM (National Library of Medicine)

state of florida doh central pharmacy - theophylline anhydrous (unii: 0i55128jyk) (theophylline anhydrous - unii:0i55128jyk) - theophylline anhydrous 200 mg - theophylline is indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. theophylline (anhydrous) extended-release tablets is contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product.